CRLF2 and acute myeloid leukemia: qChIP, assays showed significant binding of IKZF1 at the CRLF2 promoter region in both B-ALL (Nalm6 and 697) and T-ALL (CEM and MOLT-4) cells, but very weak binding in U-937 AML cells (Figure 2B).